AXIM BiotechnologiesAXIM +7.14% Market Cap is $1.53 Mil as of Jun. 25, 2026. The stock has 7 warning signs investors should review. Among 1,431 Biotechnology companies, AXIM Biotechnologies ranks worse than 97.06% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). AXIM Biotechnologies's share price for the quarter that ended in Jun. 2025 was $0.00602. AXIM Biotechnologies's Shares Outstanding (EOP) for the quarter that ended in Jun. 2025 was 332.96 Mil. Therefore, AXIM Biotechnologies's market cap for the quarter that ended in Jun. 2025 was $2.00 Mil.
AXIM Biotechnologies's quarterly market cap
increased
from Dec. 2024 ($0.61 Mil) to Mar. 2025 ($1.26 Mil) and
increased
from Mar. 2025 ($1.26 Mil) to Jun. 2025 ($2.00 Mil).
AXIM Biotechnologies's annual market cap
declined
from Dec. 2022 ($5.33 Mil) to Dec. 2023 ($4.67 Mil) and
declined
from Dec. 2023 ($4.67 Mil) to Dec. 2024 ($0.61 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. AXIM Biotechnologies's Enterprise Value for Today is $9.08 Mil.
AXIM Biotechnologies (OTCPK:AXIM) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
AXIM Biotechnologies Market Cap Related Terms
AXIM Biotechnologies Market Cap Historical Data
* Premium members only.
The historical data trend for AXIM Biotechnologies's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, AXIM Biotechnologies's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AXIM Biotechnologies Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, AXIM Biotechnologies's Market Cap distribution charts can be found below:
* The bar in red indicates where AXIM Biotechnologies's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
AXIM Biotechnologies's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AXIM Biotechnologies (AXIM) has a Market Cap of $1.53 Mil as of Jun. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on AXIM Biotechnologies and its competitors. According to the industry distribution chart, AXIM Biotechnologies ranks #1389 out of 1431 companies in the Biotechnology industry, placing it in the top 97.1%.
Is AXIM Biotechnologies' Market Cap too high?
AXIM Biotechnologies' current Market Cap is $1.53 Mil. The Biotechnology industry median Market Cap is 117.63. AXIM Biotechnologies' value of $1.53 Mil is 98.7% below this industry median. Based on the distribution chart, AXIM Biotechnologies ranks #1389 out of 1431 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does AXIM Biotechnologies' Market Cap compare to HEPA and SCNI?
According to the Biotechnology industry distribution chart, AXIM Biotechnologies ranks #1389 out of 1431 companies for Market Cap. This places AXIM Biotechnologies in the lower half of its industry. The industry median Market Cap is 117.63. AXIM Biotechnologies' value of $1.53 Mil is 98.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 117.63, based on 1,431 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AXIM Biotechnologies's current Market Cap of $1.53 Mil is 98.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on AXIM Biotechnologies and its competitors. For the Biotechnology industry, the median Market Cap is 117.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AXIM Biotechnologies's current Market Cap is $1.53 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AXIM Biotechnologies stock overvalued right now?
AXIM Biotechnologies (AXIM) has a current Market Cap of $1.53 Mil. The current Market Cap is $1.53 Mil and 98.7% below the Biotechnology industry median of 117.63. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For AXIM Biotechnologies (AXIM), the current Market Cap is $1.53 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AXIM Biotechnologies Inc is a integrated research and development company and developer of diagnostic healthcare solutions serving to enhance the health of people. The company focuses on improving the landscape for the diagnosis of ophthalmological conditions such as Dry Eye Disease through rapid diagnostic tests. Additionally, The company owns IP and has conducted research on SARS-CoV-2 (COVID-19) rapid neutralizing antibody tests to detect levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AXIM has been successfully added to your 